Lear Corporation LEA Q1 2026 Earnings Solid EPS Beat Drives Modest Share Gain GTES Q1 2026 Earnings EPS Beat Drives Positive Market Reaction Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress GPK Q1 2026 Earnings EPS Surpasses Expectations on 5598 Surprise ABEO Q1 2026 Earnings Narrowing Losses as Biotech Advances Pipeline Once Upon a Farm PBC OFRM Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Uncertainty